Showing 301 - 320 results of 42,192 for search '(( 50 ((ng decrease) OR (((we decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 1.21s Refine Results
  1. 301

    PIN1 silencing leads to decreases in the protein levels of HIF-1α. by Hyeong-jun Han (846566)

    Published 2016
    “…<p>A) Silencing of PIN1 expression via RNAi reduces the protein levels of HIF-1α in HCT116 cells. …”
  2. 302
  3. 303

    <i>Cyclocarya paliurus</i> extract activates insulin signaling via Sirtuin1 in C2C12 myotubes and decreases blood glucose level in mice with impaired insulin secretion by Hisae Yoshitomi (722082)

    Published 2017
    “…In addition, CPE enhanced tyrosine phosphorylation of insulin receptor substrate and activated phosphatidylinositol 3-kinase and protein kinase B (Akt) via sirtuin1 in C2C12 cells. Moreover, we found that oral administration of CPE (1 g/kg) to streptozotocin-induced hyperglycemic mice produced a progressive decrease in plasma glucose levels at 1 h after single dosing. …”
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308

    IFNγ increases PRL immunoreactivity in the hair follicle, whilst TNFα decreases follicular PRL immunoreactivity. by Ewan A. Langan (405804)

    Published 2013
    “…Results were pooled from 3 ♀ subjects (Aged 44–68), 14–16 HFs per group in total. In contrast, TNFα 5 ng/ml significantly decreased PRL IR (E). PRL IR is shown in (F) control hair follicles and those treated with (G) TNFα 0.5 ng/ml and (H) TNFα 5 ng/ml. …”
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314
  15. 315
  16. 316
  17. 317
  18. 318
  19. 319

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  20. 320